Implementing HIV Pre-Exposure Prophylaxis Education and Management Strategies for Providers in an STI/HIV Screening Program within an Adolescent/Young Adult Practice

Purpose: In the U.S., adolescents and young adults (AYA) account for over 20% of all new HIV infections. Young men who have sex with men (YMSM), and particularly YMSM of color, are disproportionately impacted. In 2014, MSM accounted for 83% (29,418) of the estimated new HIV diagnoses among males aged 13 and older. Pre-exposure Prophylaxis (PrEP), an FDA-approved medication regimen, provides a 92–99% reduction in HIV risk. Current research indicates awareness and utilization of PrEP is low among primary care providers. This study aimed to improve access and utilization of PrEP for AYA within a large academic AYA medical practice through an educational intervention and implementation of an evidence-based guideline (EBG).